Zhejiang Cheng Yi Pharmaceutical Co Ltd (603811) — Financial Flexibility Index
Zhejiang Cheng Yi Pharmaceutical Co Ltd (603811) has a Financial Flexibility Index of 0.17x as of September 2025. Free cash flow of CN¥60.95 Million (operating CF CN¥55.69 Million minus capex CN¥5.26 Million) represents 0% of total liabilities (CN¥362.71 Million). Check 603811 capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Zhejiang Cheng Yi Pharmaceutical Co Ltd Financial Flexibility Index (2011–2025)
Historical Financial Flexibility Index trend for Zhejiang Cheng Yi Pharmaceutical Co Ltd across 15 annual periods. For the full cash flow conversion analysis, see how efficiently does Zhejiang Cheng Yi Pharmaceutical Co Ltd generate cash.
Annual Financial Flexibility Index for Zhejiang Cheng Yi Pharmaceutical Co Ltd (2011–2025)
Year-by-year free cash flow to debt coverage for Zhejiang Cheng Yi Pharmaceutical Co Ltd. Explore how well can Zhejiang Cheng Yi Pharmaceutical Co Ltd service its debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.07x | CN¥325.79 Million | CN¥280.39 Million | CN¥304.55 Million | ▲ +86.6% |
| 2024 | 0.57x | CN¥265.60 Million | CN¥205.72 Million | CN¥463.31 Million | ▲ +50.2% |
| 2023 | 0.38x | CN¥265.63 Million | CN¥194.78 Million | CN¥696.15 Million | ▼ -42.8% |
| 2022 | 0.67x | CN¥418.79 Million | CN¥165.94 Million | CN¥628.16 Million | ▼ -22.3% |
| 2021 | 0.86x | CN¥277.60 Million | CN¥143.49 Million | CN¥323.62 Million | ▼ -14.4% |
| 2020 | 1.00x | CN¥321.48 Million | CN¥177.81 Million | CN¥320.79 Million | ▼ -42.0% |
| 2019 | 1.73x | CN¥364.82 Million | CN¥181.01 Million | CN¥211.29 Million | ▼ -39.4% |
| 2018 | 2.85x | CN¥405.82 Million | CN¥134.30 Million | CN¥142.45 Million | ▲ +99.7% |
| 2017 | 1.43x | CN¥104.75 Million | CN¥66.75 Million | CN¥73.41 Million | ▲ +2.8% |
| 2016 | 1.39x | CN¥116.71 Million | CN¥95.08 Million | CN¥84.11 Million | ▲ +21.2% |
| 2015 | 1.15x | CN¥98.73 Million | CN¥81.94 Million | CN¥86.21 Million | ▼ -13.1% |
| 2014 | 1.32x | CN¥109.12 Million | CN¥84.11 Million | CN¥82.77 Million | ▲ +143.3% |
| 2013 | 0.54x | CN¥71.76 Million | CN¥48.19 Million | CN¥132.43 Million | ▲ +74.1% |
| 2012 | 0.31x | CN¥56.01 Million | CN¥37.96 Million | CN¥179.99 Million | ▲ +152.2% |
| 2011 | 0.12x | CN¥23.82 Million | CN¥10.04 Million | CN¥193.09 Million | — |